跳至主要内容
临床试验/NCT01014143
NCT01014143已完成2 期

Evaluating Commercial Anti-Plaque Products and Oral Rinse

Colgate Palmolive1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2007年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
26
试验地点
1
主要终点
Plaque Index

研究概览

简要总结

Clinical research study to determine the anti-plaque efficacy of commerical dentifrices and an oral rinse.

详细描述

This clinical research study was to train new examiners for short term plaque clinical methodologies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
23 Years 至 81 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female volunteers at least 18 years of age.
  • Good general health.
  • Must sign informed consent form.
  • Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.
  • No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.

排除标准

  • Subjects unable or unwilling to sign the informed consent form.
  • Medical condition which requires pre-medication prior to dental visits/procedures.
  • Moderate or advanced periodontal disease or heavy dental tartar (calculus).
  • Two or more decayed untreated dental sites at screening.
  • Other disease of the hard or soft oral tissues.
  • Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
  • Use of medications that are currently affect salivary function.
  • Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #
  • Allergy to chlorhexidine.
  • Pregnant or nursing women.
  • Participation in any other clinical study within 1 week prior to enrollment into this study.
  • Use of tobacco products.
  • Subjects who must receive dental treatment during the study dates.
  • Current use of Antibiotics for pre-medication for dental treatment or for any other purpose.
  • Presence of an orthodontic appliance that interferes with plaque scoring.
  • History of allergy to common dentifrice ingredients.
  • Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy).

研究组 & 干预措施

Fluoride toothpaste

Placebo Comparator

Negative control

干预措施: Fluoride (Drug)

Triclosan/Fluoride toothpaste

Active Comparator

positive control toothpaste

干预措施: Fluoride, triclosan (Drug)

Chlorhexidine Oral Rinse

Active Comparator

Positive Control mouthrinse

干预措施: Chlorhexidine digluconate (Drug)

结局指标

主要结局

Plaque Index

时间窗: Four days

Plaque scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque,3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Evaluating Commercial Anti-Plaque Products and Oral... | 临床试验